Global Orphan Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
Orphan drugs are special effects of rare diseases. Take the concept that the orphans are lonely and lacking attention.
The report focuses on the Orphan Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Orphan Drugs market.
Major Players in the Orphan Drugs market are:
F.Hoffman-La Roche AG
Novartis AG
Merck & Co. Inc.
Johnson & Johnson Services, Inc.
Bayer
Alexion
Pfizer Inc.
Amryt Pharma PLC
Sanofi
Celgene Corporation
Brisol-Myers Squibb Company
AbbVie, Inc.
RegeneRX Biopharmaceuticals, Inc.
Shire PLC
On the basis of types, the Orphan Drugs market is primarily split into:
Oncologic Diseases
Metabolic Diseases
Hematologic and Immunologic Diseases
Infectious Diseases
Neurologic Diseases
Other Rare Diseases
On the basis of applications, the market covers:
Non-Hodgkin Lymphoma
Acute Myeloid Leukemia
Cystic Fibrosis
Glioma
Pancreatic Cancer
Ovarian Cancer
Multiple Myeloma
Duchenne Muscular Dystrophy
Graft vs Host Disease
Renal Cell Carcinoma
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Orphan Drugs Market Overview
- 1.1 Product Overview and Scope of Orphan Drugs Market
- 1.2 Orphan Drugs Market Segment by Type
- 1.2.1 Global Orphan Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Orphan Drugs Market Segment by Application
- 1.3.1 Orphan Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Orphan Drugs Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Orphan Drugs (2017-2029)
- 1.5.1 Global Orphan Drugs Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Orphan Drugs Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Orphan Drugs Industry
- 1.7 Impact of Carbon Neutrality on the Orphan Drugs Industry
- 2 Orphan Drugs Market Upstream and Downstream Analysis
- 2.1 Orphan Drugs Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Orphan Drugs Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 F.Hoffman-La Roche AG
- 3.1.1 F.Hoffman-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Orphan Drugs Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Novartis AG
- 3.2.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Orphan Drugs Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Merck & Co. Inc.
- 3.3.1 Merck & Co. Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Orphan Drugs Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Johnson & Johnson Services, Inc.
- 3.4.1 Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Orphan Drugs Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Bayer
- 3.5.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Orphan Drugs Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Alexion
- 3.6.1 Alexion Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Orphan Drugs Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Pfizer Inc.
- 3.7.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Orphan Drugs Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 Amryt Pharma PLC
- 3.8.1 Amryt Pharma PLC Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Orphan Drugs Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Sanofi
- 3.9.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Orphan Drugs Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Celgene Corporation
- 3.10.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Orphan Drugs Market Performance (2017-2022)
- 3.10.4 Business Overview
- 3.11 Brisol-Myers Squibb Company
- 3.11.1 Brisol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.11.2 Product Profiles, Application and Specification
- 3.11.3 Orphan Drugs Market Performance (2017-2022)
- 3.11.4 Business Overview
- 3.12 AbbVie, Inc.
- 3.12.1 AbbVie, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.12.2 Product Profiles, Application and Specification
- 3.12.3 Orphan Drugs Market Performance (2017-2022)
- 3.12.4 Business Overview
- 3.13 RegeneRX Biopharmaceuticals, Inc.
- 3.13.1 RegeneRX Biopharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.13.2 Product Profiles, Application and Specification
- 3.13.3 Orphan Drugs Market Performance (2017-2022)
- 3.13.4 Business Overview
- 3.14 Shire PLC
- 3.14.1 Shire PLC Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.14.2 Product Profiles, Application and Specification
- 3.14.3 Orphan Drugs Market Performance (2017-2022)
- 3.14.4 Business Overview
- 4 Global Orphan Drugs Market Landscape by Player
- 4.1 Global Orphan Drugs Sales and Share by Player (2017-2022)
- 4.2 Global Orphan Drugs Revenue and Market Share by Player (2017-2022)
- 4.3 Global Orphan Drugs Average Price by Player (2017-2022)
- 4.4 Global Orphan Drugs Gross Margin by Player (2017-2022)
- 4.5 Orphan Drugs Market Competitive Situation and Trends
- 4.5.1 Orphan Drugs Market Concentration Rate
- 4.5.2 Orphan Drugs Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Orphan Drugs Sales, Revenue, Price Trend by Type
- 5.1 Global Orphan Drugs Sales and Market Share by Type (2017-2022)
- 5.2 Global Orphan Drugs Revenue and Market Share by Type (2017-2022)
- 5.3 Global Orphan Drugs Price by Type (2017-2022)
- 5.4 Global Orphan Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Orphan Drugs Sales, Revenue and Growth Rate of Oncologic Diseases (2017-2022)
- 5.4.2 Global Orphan Drugs Sales, Revenue and Growth Rate of Metabolic Diseases (2017-2022)
- 5.4.3 Global Orphan Drugs Sales, Revenue and Growth Rate of Hematologic and Immunologic Diseases (2017-2022)
- 5.4.4 Global Orphan Drugs Sales, Revenue and Growth Rate of Infectious Diseases (2017-2022)
- 5.4.5 Global Orphan Drugs Sales, Revenue and Growth Rate of Neurologic Diseases (2017-2022)
- 5.4.6 Global Orphan Drugs Sales, Revenue and Growth Rate of Other Rare Diseases (2017-2022)
- 6 Global Orphan Drugs Market Analysis by Application
- 6.1 Global Orphan Drugs Consumption and Market Share by Application (2017-2022)
- 6.2 Global Orphan Drugs Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Orphan Drugs Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Orphan Drugs Consumption and Growth Rate of Non-Hodgkin Lymphoma (2017-2022)
- 6.3.2 Global Orphan Drugs Consumption and Growth Rate of Acute Myeloid Leukemia (2017-2022)
- 6.3.3 Global Orphan Drugs Consumption and Growth Rate of Cystic Fibrosis (2017-2022)
- 6.3.4 Global Orphan Drugs Consumption and Growth Rate of Glioma (2017-2022)
- 6.3.5 Global Orphan Drugs Consumption and Growth Rate of Pancreatic Cancer (2017-2022)
- 6.3.6 Global Orphan Drugs Consumption and Growth Rate of Ovarian Cancer (2017-2022)
- 6.3.7 Global Orphan Drugs Consumption and Growth Rate of Multiple Myeloma (2017-2022)
- 6.3.8 Global Orphan Drugs Consumption and Growth Rate of Duchenne Muscular Dystrophy (2017-2022)
- 6.3.9 Global Orphan Drugs Consumption and Growth Rate of Graft vs Host Disease (2017-2022)
- 6.3.10 Global Orphan Drugs Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
- 6.3.11 Global Orphan Drugs Consumption and Growth Rate of Others (2017-2022)
- 7 Global Orphan Drugs Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Orphan Drugs Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Orphan Drugs Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Orphan Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Orphan Drugs Market Forecast (2022-2029)
- 8.1 Global Orphan Drugs Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Orphan Drugs Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Orphan Drugs Price and Trend Forecast (2022-2029)
- 8.2 Global Orphan Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Orphan Drugs Sales and Revenue Forecast (2022-2029)
- 8.3 Global Orphan Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Orphan Drugs Revenue and Growth Rate of Oncologic Diseases (2022-2029)
- 8.3.2 Global Orphan Drugs Revenue and Growth Rate of Metabolic Diseases (2022-2029)
- 8.3.3 Global Orphan Drugs Revenue and Growth Rate of Hematologic and Immunologic Diseases (2022-2029)
- 8.3.4 Global Orphan Drugs Revenue and Growth Rate of Infectious Diseases (2022-2029)
- 8.3.5 Global Orphan Drugs Revenue and Growth Rate of Neurologic Diseases (2022-2029)
- 8.3.6 Global Orphan Drugs Revenue and Growth Rate of Other Rare Diseases (2022-2029)
- 8.4 Global Orphan Drugs Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Orphan Drugs Consumption Value and Growth Rate of Non-Hodgkin Lymphoma (2022-2029)
- 8.4.2 Global Orphan Drugs Consumption Value and Growth Rate of Acute Myeloid Leukemia (2022-2029)
- 8.4.3 Global Orphan Drugs Consumption Value and Growth Rate of Cystic Fibrosis (2022-2029)
- 8.4.4 Global Orphan Drugs Consumption Value and Growth Rate of Glioma (2022-2029)
- 8.4.5 Global Orphan Drugs Consumption Value and Growth Rate of Pancreatic Cancer (2022-2029)
- 8.4.6 Global Orphan Drugs Consumption Value and Growth Rate of Ovarian Cancer (2022-2029)
- 8.4.7 Global Orphan Drugs Consumption Value and Growth Rate of Multiple Myeloma (2022-2029)
- 8.4.8 Global Orphan Drugs Consumption Value and Growth Rate of Duchenne Muscular Dystrophy (2022-2029)
- 8.4.9 Global Orphan Drugs Consumption Value and Growth Rate of Graft vs Host Disease (2022-2029)
- 8.4.10 Global Orphan Drugs Consumption Value and Growth Rate of Renal Cell Carcinoma (2022-2029)
- 8.4.11 Global Orphan Drugs Consumption Value and Growth Rate of Others (2022-2029)
- 8.5 Orphan Drugs Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Orphan Drugs Market Drivers Analysis
- 9.2 Orphan Drugs Market Restraints and Challenges
- 9.3 Orphan Drugs Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Orphan Drugs Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Orphan Drugs Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Orphan Drugs Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook